Article

Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost

2021-04-05

Abstract excerpt

The emergence of SARS-CoV-2 Variants of Concern (VOCs) with mutations in key neutralizing antibody epitopes threatens to undermine vaccines developed against the pandemic founder variant (Wu-Hu-1). Widespread vaccine rollout and continued transmission are creating a population that has antibody responses of varying potency to Wu-Hu-1. Against this background, it is critical to assess the outcomes of subsequent imm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 408fac68-7eaf-55ef-b7f5-8ba074a73e75
DOI: 10.1101/2021.04.03.438330

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boostDOI 10.1101/2021.04.03.438330Read

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal modelsSemantic proximity Read

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.Semantic proximity Read

Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ VaccinationSemantic proximity Read

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesSemantic proximity Read

A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralizationSemantic proximity Read

SARS-CoV-2 preS dTM vaccine booster candidates increase functional antibody responses and cross-neutralization against SARS-CoV-2 variants of concern in non-human primatesSemantic proximity Read

Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccinationSemantic proximity Read

Wobble Vaccines: Complex Vaccine Antigen Pools Promote Increased Antibody Breadth and Cross-Strain Viral Targeting in SARS-CoV-2Semantic proximity Read

Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine dosesSemantic proximity Read

Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsSemantic proximity Read

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.Semantic proximity Read

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2Semantic proximity Read